Fulgent Genetics (FLGT) Non-Current Deferred Tax Liability (2016 - 2025)
Fulgent Genetics' Non-Current Deferred Tax Liability history spans 6 years, with the latest figure at $7.0 million for Q3 2025.
- For Q3 2025, Non-Current Deferred Tax Liability rose 4.54% year-over-year to $7.0 million; the TTM value through Sep 2025 reached $7.0 million, up 4.54%, while the annual FY2024 figure was $6.4 million, 19.99% down from the prior year.
- Non-Current Deferred Tax Liability for Q3 2025 was $7.0 million at Fulgent Genetics, up from $6.1 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $9.8 million in Q3 2023 and bottomed at $6.1 million in Q2 2025.
- The 3-year median for Non-Current Deferred Tax Liability is $6.9 million (2024), against an average of $7.2 million.
- The largest annual shift saw Non-Current Deferred Tax Liability tumbled 31.52% in 2024 before it grew 4.54% in 2025.
- A 3-year view of Non-Current Deferred Tax Liability shows it stood at $8.0 million in 2023, then decreased by 19.99% to $6.4 million in 2024, then increased by 10.52% to $7.0 million in 2025.
- Per Business Quant, the three most recent readings for FLGT's Non-Current Deferred Tax Liability are $7.0 million (Q3 2025), $6.1 million (Q2 2025), and $6.2 million (Q1 2025).